Skip to content

A Prospective, Multicenter Randomized Controlled Study on the Clinical Application of Ultrasound-Guided Implantation of Intra-arterial and Intra-venous Port Systems for Intravenous Access

A Prospective, Multicenter Randomized Controlled Study on the Clinical Application of Ultrasound-Guided Implantation of Intra-arterial and Intra-venous Port Systems for Intravenous Access

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113356
Enrollment
Unknown
Registered
2025-11-27
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Interventions

Transjugular Intrahepatic Vein Appendage Placement:Using a high-frequency ultrasound probe to visualize the right internal jugular vein: Guide the probe downward along the vein to assess its diameter

Sponsors

The Second Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Cancer patients aged over 18 years; 2. With a predicted survival period exceeding 3 months; 3. Requiring infusion of irritant or cytotoxic agents such as chemotherapy drugs or targeted therapies; 4. Requiring prolonged infusion of hypertonic solutions including parenteral nutrition; 5. Requiring continuous or intermittent intravenous infusion therapy; 6. Requiring repeated transfusion of blood products; 7. Requiring frequent blood sampling for monitoring purposes.

Exclusion criteria

Exclusion criteria: 1. Patients with uncontrolled local infection or concurrent acute systemic infection that cannot be effectively managed; 2. Venous return disorders such as superior vena cava syndrome or thrombosis at the puncture site; 3. Patients who have undergone right breast cancer surgery or are scheduled for right chest surgery; 4. Head and neck or pulmonary tumours where the radiotherapy field overlaps the intended port placement site in the right chest; 5. Severe coagulation disorders (prothrombin time or activated partial thromboplastin time prolonged by more than twofold, INR > 2.0, platelet count below 30 × 10?/L); 6. Known allergy to port materials such as silicone, polyurethane, or titanium.

Design outcomes

Primary

MeasureTime frame
First-attempt puncture success rate;

Secondary

MeasureTime frame
Incidence of perioperative complications;Postoperative complication incidence rate;Surgery time;Tube length;comfort level;Tube retention time;

Countries

China

Contacts

Public ContactSun Xingwei

The Second Affiliated Hospital of Soochow University

sdfeysxw@163.com+86 151 0613 8083

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026